Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 13918-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#13918-1-AP, RRID:AB_2238079
- Product name
- RBM17 antibody
- Antibody type
- Polyclonal
- Description
- RBM17 antibody (Cat. #13918-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references RBM17 Promotes the Chemoresistance of Oral Squamous Cancer Cells Through Checkpoint Kinase 1.
Development of a circadian-related prognostic signature highlights RBM17 as a stemness regulator in liver cancer.
RBM17 promotes hepatocellular carcinoma progression by regulating lipid metabolism and immune microenvironment: implications for therapeutic targeting.
CircSCAP interacts with SF3A3 to inhibit the malignance of non-small cell lung cancer by activating p53 signaling.
Interactome network analysis identifies multiple caspase-6 interactors involved in the pathogenesis of HD.
Nakahara M, Arai R, Tokuoka I, Fukumura K, Mayeda A, Yashiro M, Nakahara H
International journal of molecular sciences 2025 Mar 28;26(7)
International journal of molecular sciences 2025 Mar 28;26(7)
Development of a circadian-related prognostic signature highlights RBM17 as a stemness regulator in liver cancer.
Yan J, Yang X, Lu J, Wu S, Wang Y, Du Y, Zheng J, Wang F, Gao H, Yang H, Xi S, Li Y
Cancer cell international 2025 Jun 13;25(1):211
Cancer cell international 2025 Jun 13;25(1):211
RBM17 promotes hepatocellular carcinoma progression by regulating lipid metabolism and immune microenvironment: implications for therapeutic targeting.
Wang Z, Liu J, Lai Y, Zhong Q, Su Q, Wu L, Wang Z, Fang Z
Cell death discovery 2025 Jul 23;11(1):338
Cell death discovery 2025 Jul 23;11(1):338
CircSCAP interacts with SF3A3 to inhibit the malignance of non-small cell lung cancer by activating p53 signaling.
Chen D, Zhou H, Cai Z, Cai K, Liu J, Wang W, Miao H, Li H, Li R, Li X, Chen Y, Wang HY, Wen Z
Journal of experimental & clinical cancer research : CR 2022 Apr 1;41(1):120
Journal of experimental & clinical cancer research : CR 2022 Apr 1;41(1):120
Interactome network analysis identifies multiple caspase-6 interactors involved in the pathogenesis of HD.
Riechers SP, Butland S, Deng Y, Skotte N, Ehrnhoefer DE, Russ J, Laine J, Laroche M, Pouladi MA, Wanker EE, Hayden MR, Graham RK
Human molecular genetics 2016 Apr 15;25(8):1600-18
Human molecular genetics 2016 Apr 15;25(8):1600-18
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- BxPC-3 cells were subjected to SDS PAGE followed by western blot with 13918-1-AP(RBM17 antibody) at dilution of 1:800
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of Hela cells, using RBM17 antibody 13918-1-AP at 1:50 dilution and Rhodamine-labeled goat anti-rabbit IgG (red). Blue pseudocolor = DAPI (fluorescent DNA dye).
- Sample type
- cell line
